Over the past year there were no insider purchases at Dianthus Therapeutics, Inc.. Eight insiders sold roughly $71.2 million instead.
Keep in mind most insider selling is routine — stock-based pay has to be converted to cash at some point.
5 quarters in a row of net selling by insiders. Insiders bought in 0 of the last 7 full quarters. Big money check: 269 institutions held DNTH as of Q2 2026, and more funds bought than sold.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Sep 18, 2026 | CARR EDWARD | Executive Officer | Sell | 7,928 | $100.43 | $796K | SEC |
| Sep 18, 2026 | CARR EDWARD | Executive Officer | Sell | 6,771 | $101.37 | $686K | SEC |
| Sep 18, 2026 | CARR EDWARD | Executive Officer | Sell | 3,501 | $102.39 | $358K | SEC |
| Sep 18, 2026 | CARR EDWARD | Executive Officer | Sell | 700 | $104.39 | $73K | SEC |
| Sep 18, 2026 | CARR EDWARD | Executive Officer | Sell | 1,100 | $103.20 | $114K | SEC |
| Sep 3, 2026 | Randhawa Simrat | Executive Officer | Sell | 2,600 | $105.19 | $273K | SEC |
| Sep 3, 2026 | Randhawa Simrat | Executive Officer | Sell | 7,215 | $106.25 | $767K | SEC |
| Sep 3, 2026 | Randhawa Simrat | Executive Officer | Sell | 13,309 | $106.74 | $1.4M | SEC |
| Aug 19, 2026 | Read Simon | Director | Sell | 2,778 | $117.55 | $327K | SEC |
| Aug 11, 2026 | McGeorge Anne | Director | Sell | 2,800 | $108.38 | $303K | SEC |
| Aug 11, 2026 | McGeorge Anne | Director | Sell | 1,450 | $107.58 | $156K | SEC |
| Aug 11, 2026 | Read Simon | Director | Sell | 70 | $107.11 | $7K | SEC |
| Aug 11, 2026 | Read Simon | Director | Sell | 397 | $111.77 | $44K | SEC |
| Aug 11, 2026 | Read Simon | Director | Sell | 470 | $111.05 | $52K | SEC |
| Aug 11, 2026 | Veness Adam M | Executive Officer | Sell | 3,217 | $110.61 | $356K | SEC |
In the last 12 months Dianthus Therapeutics, Inc. insiders made open-market purchases worth about $0 and sales worth about $71.2 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in DNTH was filed on 2026-09-18.
269 investment managers reported holding DNTH in SEC Form 13F filings for Q2 2026.
No congressional trades in DNTH were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).